Wei Ting Wu from Rockville, MD, age 58

Professional Records

Medicine Doctors

Wei Thyain Wu

Specialties:

Obstetrics & Gynecology

Education:

Taipei Medical University (1972)

Lawyers & Attorneys

Wei Wu - Lawyer

Address:

Baker & Mackenzie, Beijing Office
(106) 535-3860 (Office)

Licenses:

New York - Currently registered 2007

Education:

Harvard Law School

Specialties:

Litigation - 34%
Arbitration - 33%
Contracts / Agreements - 33%

Business Records

Name / Title

Company / Classification

Phones & Addresses

Wei Yu Wu
Director, President, Treasurer

Eming Inc

Wei M. Wu
Principal

D.H. Kim Enterprises, Inc
Carpentry Contractor

3303 Stanton Rd SE, Washington, DC 20020
(202) 889-3893

Wei Wu
Managing

B & W Publishing LLC

Wei Wu

TRIPLE ARROW INDUSTRIES, INC

Wei Wu
Treasurer

USA Belle Electric Automobile Inc

Wei Wu
Treasurer

USA Blueribbon Group Inc

Wei Wu
Treasurer

USA Blueribbon Beer Inc

Wei Min Wu
M

Tovar Clothing LLC

Publications

Us Patents

Cd80 And Cd86 Binding Protein Compositions And Uses Thereof

US Patent:

20220259285, Aug 18, 2022

Filed:

Feb 22, 2022

Appl. No.:

17/677795

Inventors:

- Rockville MD, US
- Washington DC, US
Martin DEVENPORT - Gaithersburg MD, US
Wei WU - Washington DC, US
Xuexiang DU - Washington DC, US
Mingyue LIU - Washington DC, US
Fei TANG - Washington DC, US

Assignee:

ONCOC4, INC. - Rockville MD
CHILDREN'S NATIONAL MEDICAL CENTER - Washington DC

International Classification:

C07K 14/705
A61P 37/06
A61P 35/00
C07K 16/28
A61K 39/395
C07K 14/00

Abstract:

This invention relates to CTLA-4 protein compositions and their use in the mitigation of autoimmune adverse events associated with cancer immunotherapy.

Cd80 And Cd86 Binding Protein Compositions And Uses Thereof

US Patent:

20220259286, Aug 18, 2022

Filed:

Feb 22, 2022

Appl. No.:

17/677814

Inventors:

- Rockville MD, US
- Washington DC, US
Martin DEVENPORT - Gaithersburg MD, US
Wei WU - Washington DC, US
Xuexiang DU - Washington DC, US
Mingyue LIU - Washington DC, US
Fei TANG - Washington DC, US

Assignee:

ONCOC4, INC. - Rockville MD
CHILDREN'S NATIONAL MEDICAL CENTER - Washington DC

International Classification:

C07K 14/705
A61P 37/06
A61P 35/00
C07K 16/28
A61K 39/395
C07K 14/00

Abstract:

This invention relates to CTLA-4 protein compositions and their use in the mitigation of autoimmune adverse events associated with cancer immunotherapy.

Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis

US Patent:

20200399345, Dec 24, 2020

Filed:

Sep 1, 2020

Appl. No.:

17/009540

Inventors:

- Rockville MD, US
Wei Wu - Washington DC, US
Yang Liu - Baltimore MD, US
Pan Zheng - Baltimore MD, US

Assignee:

OncoImmune, Inc. - Rockville MD

International Classification:

C07K 14/705
C07K 14/435
C07K 19/00
C07K 14/47

Abstract:

Provided herein is a CD24 protein. The CD24 protein may include mature human or mouse CD24, as well as a N- or C-terminally fused portion of a mammalian immunoglobulin.

Cd80 And Cd86 Binding Protein Compositions And Uses Thereof

US Patent:

20190263889, Aug 29, 2019

Filed:

Sep 19, 2017

Appl. No.:

16/333888

Inventors:

- Rockville MD, US
- Washington DC, US
Martin DEVENPORT - Gaithersburg MD, US
Wei WU - Washington DC, US
Xuexiang DU - Washington DC, US
Mingyue LIU - Washington DC, US
Fei TANG - Washington DC, US

Assignee:

ONCOIMMUNE, INC. - Rockville MD
CHILDREN'S RESEARCH INSTITUTE, CHILDREN'S NATIONAL MEDICAL CENTER - Washington DC

International Classification:

C07K 14/705
C07K 16/28
A61P 35/00
A61P 37/06

Abstract:

This invention relates to cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) protein compositions and their use in the mitigation of autoimmune adverse events associated with cancer immunotherapy. Specifically, the disclosure provides a CTLA-4 protein comprising a mutant extracellular domain of CTLA-4, wherein the CTLA-4 protein exhibits reduced binding to an anti-CTLA-4 antibody as compared to a wild-type extracellular domain of CTLA-4, wherein the anti-CTLA-4 antibody has anti-cancer immunotherapeutic activity.

Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis

US Patent:

20190016783, Jan 17, 2019

Filed:

Aug 16, 2018

Appl. No.:

16/104072

Inventors:

- ROCKVILLE MD, US
Wei Wu - Washington DC, US
Yang Liu - Washington DC, US
Pan Zheng - Washington DC, US

Assignee:

ONCOLMMUNE, INC. - ROCKVILLE MD

International Classification:

C07K 14/705
C07K 14/47
C07K 14/435
C07K 19/00

Abstract:

Provided herein is a CD24 protein. The CD24 protein may include mature human or mouse CD24, as well as a N- or C-terminally fused portion of a mammalian immunoglobulin.

Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis

US Patent:

20170233453, Aug 17, 2017

Filed:

Feb 21, 2017

Appl. No.:

15/437968

Inventors:

- Rockville MD, US
Wei Wu - Washington DC, US
Yang Liu - Washington DC, US
Pan Zheng - Washington DC, US

International Classification:

C07K 14/705

Abstract:

Provided herein is a CD24 protein. The CD24 protein may include mature human or mouse CD24, as well as a N- or C-terminally fused portion of a mammalian immunoglobulin.